100 related articles for article (PubMed ID: 28539956)
1. Serum Prolactin Levels in Patients with Major Depressive Disorder Receiving Selective Serotonin-Reuptake Inhibitor Monotherapy for 3 Months: A Prospective Study.
Park YM
Psychiatry Investig; 2017 May; 14(3):368-371. PubMed ID: 28539956
[TBL] [Abstract][Full Text] [Related]
2. Serum prolactin and macroprolactin levels among outpatients with major depressive disorder following the administration of selective serotonin-reuptake inhibitors: a cross-sectional pilot study.
Kim S; Park YM
PLoS One; 2013; 8(12):e82749. PubMed ID: 24312671
[TBL] [Abstract][Full Text] [Related]
3. Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants, Prolactin and Breast Cancer.
Ashbury JE; Lévesque LE; Beck PA; Aronson KJ
Front Oncol; 2012; 2():177. PubMed ID: 23227451
[TBL] [Abstract][Full Text] [Related]
4. Frontoparietal Activation During Response Inhibition Predicts Remission to Antidepressants in Patients With Major Depression.
Gyurak A; Patenaude B; Korgaonkar MS; Grieve SM; Williams LM; Etkin A
Biol Psychiatry; 2016 Feb; 79(4):274-81. PubMed ID: 25891220
[TBL] [Abstract][Full Text] [Related]
5. An observational study of duloxetine versus SSRI monotherapy in Japanese patients with major depressive disorder: subgroup analyses of treatment effectiveness for pain, depressive symptoms, and quality of life.
Kuga A; Tsuji T; Hayashi S; Fujikoshi S; Tokuoka H; Yoshikawa A; Escobar R; Tanaka K; Azekawa T
Neuropsychiatr Dis Treat; 2017; 13():2115-2124. PubMed ID: 28831260
[TBL] [Abstract][Full Text] [Related]
6. Escitalopram: a pharmacoeconomic review of its use in depression.
Croom KF; Plosker GL
Pharmacoeconomics; 2003; 21(16):1185-209. PubMed ID: 14594439
[TBL] [Abstract][Full Text] [Related]
7. An observational study of duloxetine versus SSRI monotherapy for the treatment of painful physical symptoms in Japanese patients with major depressive disorder: primary analysis.
Kuga A; Tsuji T; Hayashi S; Matsubara M; Fujikoshi S; Tokuoka H; Yoshikawa A; Escobar R; Tanaka K; Azekawa T
Neuropsychiatr Dis Treat; 2017; 13():2105-2114. PubMed ID: 28831259
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of hyperprolactinemia in schizophrenic patients treated with conventional antipsychotic medications or risperidone.
Kinon BJ; Gilmore JA; Liu H; Halbreich UM
Psychoneuroendocrinology; 2003 Apr; 28 Suppl 2():55-68. PubMed ID: 12650681
[TBL] [Abstract][Full Text] [Related]
9. A case of galactorrhea associated with excitalopram.
Shim SH; Lee YJ; Lee EC
Psychiatry Investig; 2009 Sep; 6(3):230-2. PubMed ID: 20046401
[TBL] [Abstract][Full Text] [Related]
10. Emerging Hyperprolactinemic Galactorrhea in Obsessive Compulsive Disorder with a Stable Dose of Fluoxetine.
Chatterjee SS; Mitra S; Mallik N
Clin Psychopharmacol Neurosci; 2015 Dec; 13(3):316-8. PubMed ID: 26598592
[TBL] [Abstract][Full Text] [Related]
11. Analysis of treatment patterns and persistence on branded and generic medications in major depressive disorder using retrospective claims data.
Solem CT; Shelbaya A; Wan Y; Deshpande CG; Alvir J; Pappadopulos E
Neuropsychiatr Dis Treat; 2016; 12():2755-2764. PubMed ID: 27822048
[TBL] [Abstract][Full Text] [Related]
12. Selective serotonin reuptake inhibitors (SSRIs) prevent meta-iodobenzylguanidine (MIBG) uptake in platelets without affecting neuroblastoma tumor uptake.
Blom T; Meinsma R; Rutgers M; Buitenhuis C; Dekken-Van den Burg M; van Kuilenburg ABP; Tytgat GAM
EJNMMI Res; 2020 Jul; 10(1):78. PubMed ID: 32642907
[TBL] [Abstract][Full Text] [Related]
13. The role of selective serotonin reuptake inhibitors in preventing relapse of major depressive disorder.
Clevenger SS; Malhotra D; Dang J; Vanle B; IsHak WW
Ther Adv Psychopharmacol; 2018 Jan; 8(1):49-58. PubMed ID: 29344343
[TBL] [Abstract][Full Text] [Related]
14. Sexual dysfunction in selective serotonin reuptake inhibitors (SSRIs) and potential solutions: A narrative literature review.
Jing E; Straw-Wilson K
Ment Health Clin; 2016 Jul; 6(4):191-196. PubMed ID: 29955469
[TBL] [Abstract][Full Text] [Related]
15. Risperidone added to clozapine: impact on serum prolactin levels.
Henderson DC; Goff DC; Connolly CE; Borba CP; Hayden D
J Clin Psychiatry; 2001 Aug; 62(8):605-8. PubMed ID: 11561931
[TBL] [Abstract][Full Text] [Related]
16. Escitalopram: a second-generation SSRI.
Owens MJ; Rosenbaum JF
CNS Spectr; 2002 Apr; 7(4 Suppl 1):34-9. PubMed ID: 15131491
[TBL] [Abstract][Full Text] [Related]
17. Escitalopram-Induced Amenorrhea and False Positive Urine Pregnancy Test.
Selvaraj V; Hour S; Gunasekar P; Gray C; Smith JF
Korean J Fam Med; 2017 Jan; 38(1):40-42. PubMed ID: 28197332
[TBL] [Abstract][Full Text] [Related]
18. Unilateral Galactorrhea Associated with Low-dose Escitalopram.
Ravi PB; Guruprasad KG; Andrade C
Indian J Psychol Med; 2014 Jul; 36(3):344-5. PubMed ID: 25035569
[TBL] [Abstract][Full Text] [Related]
19. Hyperprolactinemia and breast enlargement with serotonin reuptake inhibitor and olanzapine combination.
Praharaj SK
Indian J Pharmacol; 2011 Nov; 43(6):739-40. PubMed ID: 22144791
[No Abstract] [Full Text] [Related]
20. Metabolic Effects of Antidepressant Treatment.
Olguner Eker Ö; Özsoy S; Eker B; Doğan H
Noro Psikiyatr Ars; 2017 Mar; 54(1):49-56. PubMed ID: 28566959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
